Covid-19 antiviral pilots

The government announced this month that thousands of the UK’s most vulnerable people will be among the first in the world to access a new antiviral treatment for Covid-19, Molnupiravir. This will take the form of pilot prescribing antivirals to vulnerable people who have caught Covid-19 and a study combining providing antivirals and placebos to healthier people. The Government press release announcing these can be read here.

NHS antiviral prescribing for vulnerable patients

The NHS has confirmed that it will begin offering Molnupiravir from 16 December, to patients who are at the highest risk of becoming seriously ill with coronavirus. Those eligible must be over 12 years old and live with a condition that makes Covid-19 especially dangerous, such as Down’s Syndrome or certain types of cancer. If the NHS considers the antiviral treatment appropriate for an individual, a hospital pharmacy will arrange for the medicine to be delivered to your home. Molnupiravir is administered in capsules to be swallowed.

The full list of eligible patients and more details for the public can be read here. Eligibility closely corresponds to the shielding list criteria used earlier in the pandemic. Further information from the MHRA can be accessed here.

Study of antiviral use in healthy patients

Separately, the University of Oxford, in close collaboration with GP hubs, has launched a national study called PANORAMIC, which will provide 10,000 people with the opportunity to take Molnupiravir at home after testing positive. To participate in the study, individuals must be aged 50 or over or have a pre-existing health condition. 215 participants have currently been recruited across 21 NHS sites across the UK. If eligible, individuals who have tested positive will be contacted by the study team or a local healthcare professional, such as their GP. People can also find out if they meet the requirements at www.panoramictrial.org.

 

 

Last updated : 16 Dec 2021

 

GMC publish new consent guidance (21 Oct 2020)

The GMC have updated their guidance in relation to consent – the guidance comes into effect on 9 November 2020 and can be accessed at the link below: Guidance...
Read more »

Health Select Committee pandemic report (21 Oct 2020)

Amongst other things,Parliament’s Health and Social Care Select Committee called for improvements in referral handling at the primary/secondary care interface, better staff testing (including for GPs and staff) and quoted...
Read more »

Tips of the Month October 2020 (21 Oct 2020)

We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »

NHS 111 First roll-out (21 Oct 2020)

By 1 December NHS 111 will be able to book appointments at emergency departments (EDs) within all London hospitals. This will coincide with a campaign encouraging patients to contact NHS...
Read more »

Calling all general practice managers, business managers, HR managers, finance managers, operational managers, managing partners and site managers (24 Sep 2020)

As part of our Practice Manager Development project, we are able to offer you an opportunity to take-up a fully...
Read more »

Appraisal resumes and GMC to consider Coronavirus impact during investigations (23 Sep 2020)

NHS England has instructed GPs to resume the appraisal process from 1 October, although this will be in a form which is intended to reduce the amount of paperwork involved,...
Read more »

Coronavirus protection for London general practice (23 Sep 2020)

As the only truly independent voice for London general practice, Londonwide LMCs continues to provide constructive challenge on behalf of GPs, nurses and the whole team in each and every...
Read more »

London level Coronavirus response (23 Sep 2020)

We continue to provide an active voice for London general practice, working with the Mayor’s Office, London Assembly and London Councils to raise awareness of the needs of GP practices...
Read more »
Next Page »
« Previous Page